PCL

PCL Liabilities

The The Liabilities of PCL (241820.KQ) as of Nov 3, 2026 is 14.46 B KRW. In the previous year, The Liabilities was 24.58 B KRW — a change of -41.18% (lower).

Liabilities

14.46 BKRW

YoY

-41.18%

Last updated:

In 2024, PCL's total liabilities amounted to 14.46 B KRW, a -41.18% difference from the 24.58 B KRW total liabilities in the previous year.

The PCL Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Liabilities
Date
Liabilities
Jan 1, 2017
437.22 M KRW
Jan 1, 2018
878.46 M KRW
Jan 1, 2019
9.92 B KRW
Jan 1, 2020
6.81 B KRW
Jan 1, 2021
64.75 B KRW
Jan 1, 2022
56.38 B KRW
Jan 1, 2023
24.58 B KRW
Jan 1, 2024
14.46 B KRW
The PCL Liabilities history
YEARLiabilitiesYoY
14.46 BKRW-41.18%
24.58 BKRW-56.40%
56.38 BKRW-12.92%
64.75 BKRW+850.69%
6.81 BKRW-31.37%
9.92 BKRW+1,029.65%
878.46 MKRW+100.92%
437.22 MKRW-69.67%
1.44 BKRW-9.28%
1.59 BKRW-80.37%
8.09 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

PCL Stock analysis

What does PCL do? PCL Inc, a South Korean company listed on the Korea Exchange with ticker 241820.KQ and ISIN KR7241820000, operates in the Health Care sector. Headquartered in Seoul, the company has 72 employees. It completed its initial public offering on February 23, 2017. PCL Inc focuses on the manufacturing of medical devices, with its product portfolio including blood bank screening products and quick diagnostic products. The company also provides platform services as part of its business offerings. Its official website is http://www.pclchip.com. The company's operations are based in Seoul, South Korea, and it serves the health care industry through its specialized medical device solutions and platform services. PCL is one of the most popular companies on Eulerpool.

Liabilities Details

Assessing PCL's Liabilities

PCL's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating PCL's financial stability, operational efficiency, and long-term viability.

Year-to-Year Comparison

By comparing PCL's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.

Impact on Investments

PCL's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.

Interpreting Liability Fluctuations

Shifts in PCL’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.

Frequently Asked Questions about PCL stock

The Liabilities of PCL is 14.46 B KRW in 2024.

The Liabilities of PCL changed from 24.58 B KRW to 14.46 B KRW, representing a -41.18% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Liabilities PCL since 2006 – with annual values, charts, and detailed analysis.

The Liabilities's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Liabilities's PCL historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — PCL

All Key Metrics — PCL